Detalhe da pesquisa
1.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363833
2.
Unintentional guideline deviations in hospitalized patients with two or more antithrombotic agents: an intervention study.
Eur J Clin Pharmacol
; 77(12): 1919-1926, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34319470
3.
Guidelines for mono, double and triple antithrombotic therapy.
Postgrad Med J
; 97(1153): 730-737, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33441477
4.
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.
Lancet Oncol
; 21(1): 80-94, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838009
5.
Drug-drug interactions with metronidazole and itraconazole in patients using acenocoumarol.
Eur J Clin Pharmacol
; 76(10): 1457-1464, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524154
6.
Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
Cancer Rep (Hoboken)
; 5(2): e1470, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34145976
7.
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Lancet Haematol
; 9(3): e190-e199, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35240075
8.
The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity.
Br J Haematol
; 142(2): 273-83, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18492117
9.
Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.
Clin Cancer Res
; 13(1): 307-15, 2007 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17170077
10.
Principles of dendritic cell-based immunotherapy in myeloid leukemia.
Immunobiology
; 211(6-8): 663-76, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16920505
11.
Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia.
Immunobiology
; 211(6-8): 677-85, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16920506
12.
Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia.
Haematologica
; 91(3): 348-55, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16531258
13.
Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization.
Immunobiology
; 210(2-4): 249-57, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16164032
14.
Divergent autologous T cell responses to leukaemic dendritic cells during remission in acute promyelocytic leukaemia.
Cell Oncol
; 27(4): 261-6, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16308476
15.
Malignant cutaneous lesions.
BMJ Case Rep
; 20152015 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26272959
16.
Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometry.
Cytometry A
; 66(1): 71-7, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15895438
17.
Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
Cancer Immunol Immunother
; 52(7): 455-62, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12690520